Zoledronic Acid Concept

Vocabulary Service

MeSH

Overview

subject area of

A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial Academic Article
A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases. Academic Article
Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture Academic Article
Association between timing of zoledronic acid infusion and hip fracture healing Academic Article
Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review Academic Article
Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline Academic Article
Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors Academic Article
Changes in cross-sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate) Academic Article
Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study Academic Article
Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma Academic Article
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12 Academic Article
Effect of bisphosphonates on pain and quality of life in patients with bone metastases Academic Article
Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer Academic Article
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study Academic Article
Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints Academic Article
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. Academic Article
Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer Academic Article
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid Academic Article
Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture Academic Article
Optimal management of metastatic bone disease Academic Article
Optimal management of metastatic bone disease Academic Article
Oral bisphosphonates Academic Article
Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study Academic Article
Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study Academic Article
Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy Academic Article
Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid Conference Paper
Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer Academic Article
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update Academic Article
Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture Academic Article
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers Academic Article
The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair Academic Article
The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function Conference Paper
The Use of Zoledronic Acid, a Novel, Highly Potent Bisphosphonate, for the Treatment of Hypercalcemia of Malignancy Academic Article
Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study Academic Article
Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease Academic Article
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline Academic Article
Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis Academic Article
Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis Academic Article
Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials Academic Article
Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity Academic Article
Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity Academic Article
Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. Academic Article
Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program Academic Article
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion Academic Article
Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial Academic Article
Zoledronic acid use in cancer patients Academic Article